Kepler Capital Keeps Their Hold Rating on Sanofi (SNYNF)
TipRanksApr 26 21:45 ET
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Yahoo FinanceApr 26 11:34 ET
Sobi Receives Positive CHMP Opinion Recommending Approval Of Efanesoctocog Alfa For Once-Weekly Treatment Of Haemophilia A
Sobi today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treat
BenzingaApr 26 08:06 ET
Research Alert: CFRA Keeps Buy Opinion On Adss Of Sanofi
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We adjust our target price by $3 to $57,
MT NewswiresApr 26 00:40 ET
Media Update: New Data Presented at ATS Demonstrate Sanofi's Leadership in Advancing Potential New Therapies for Patients With Immune-mediated Respiratory Diseases
New data presented at ATS demonstrate Sanofi's leadership in advancing potential new therapies for patients with immune-mediated respiratory diseasesLate-breaking data from the landmark NOTUS and BORE
SanofiApr 26 00:00 ET
Top Gap Ups and Downs on Thursday: META, AZN, CAT and More
Gaps can show signals that something important has happened to the fundamental or the psychology of traders that accompanies this market movement.
moomoo NewsApr 25 20:13 ET
DZ BANK AG Keeps Their Hold Rating on Sanofi (SNYNF)
TipRanksApr 25 14:35 ET
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
Thursday, AbbVie Inc (NASDAQ:ABBV) released topline results from LEVEL UP, an open-label, efficacy assessor-blinded head-to-head Phase 3b/4 study of upadacitinib (Rinvoq, 15 mg once daily starting dos
BenzingaApr 25 13:58 ET
Sanofi SA Starts 2024 With Strong Sales Growth
TipRanksApr 25 12:01 ET
Earnings Call Summary | Sanofi(SNY.US) Q1 2024 Earnings Conference
The following is a summary of the Sanofi (SNY) Q1 2024 Earnings Call Transcript:Financial Performance:Sanofi reported a 7% growth in Q1 2024 sales, driven by product launches and biopharma medicine fo
moomoo AIApr 25 11:58 ET · Conference Call
20 Fastest Growing Health Tech Companies in the World
Yahoo FinanceApr 25 11:34 ET
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.24% to 1,364.10 on the S&P Europe Select ADR Index. From continental Europe,
MT NewswiresApr 25 11:06 ET
Jefferies Sticks to Its Buy Rating for Sanofi (SNYNF)
TipRanksApr 25 10:35 ET
Sanofi Reports Strong Earnings, Joins Kirby, Sonic Automotive, Union Pacific And Other Big Stocks Moving Higher On Thursday
U.S. stocks were lower, with the Dow Jones falling over 600 points on Thursday.Shares of Sanofi SA (NASDAQ:SNY) rose sharply during Thursday's session following better-than-expected first-quarter earn
BenzingaApr 25 10:15 ET
Sanofi 1Q Exceeds Expectations, Beyfortus Drug Launch in Focus -- Market Talk
1316 GMT - Sanofi's 1Q beat sales and profit expectations thanks to the performance of anti-inflammatory drug Dupixent and the better-than-expected launch of lung disease treatment Beyfortus, Jefferie
WSJApr 25 09:30 ET
Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday
Health care stocks were leaning lower pre-bell Thursday, with the Health Care Select Sector SPDR Fund (XLV) unchanged and the iShares Biotechnology ETF (IBB) down 0.1%. AstraZeneca (AZN) shares were u
MT NewswiresApr 25 09:01 ET
Sanofi Q1 Profit Weak, But Sales Rise; Backs FY24 View; Stock Up
RTTNewsApr 25 08:11 ET
US stock outlook | Futures of the three major stock indexes fell sharply, and Microsoft (MSFT.US) and Alphabet (GOOGL.US) announced financial reports after the market
On April 25 (Thursday), the futures of the three major US stock indexes fell sharply before the US stock market.
Zhitong FinanceApr 25 07:59 ET
SNY Earnings: Sanofi Jumps on Healthy Q1 Performance
TipRanksApr 25 06:47 ET
US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platforms, Inc.'s (NASDAQ:META) lukewarm second-quarter revenue guidance and com
BenzingaApr 25 06:17 ET
No Data
No Data